15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Neuroleptic malignant syndrome.

      The American Journal of Psychiatry
      Adolescent, Adult, Aged, Antipsychotic Agents, adverse effects, pharmacology, Basal Ganglia Diseases, diagnosis, Bromocriptine, therapeutic use, Child, Dantrolene, Diagnosis, Differential, Dopamine, physiology, Dopamine Antagonists, Female, Humans, Male, Malignant Hyperthermia, Middle Aged, Neuroleptic Malignant Syndrome, drug therapy, physiopathology, Psychotic Disorders, Receptors, Dopamine, drug effects, Rhabdomyolysis, Schizophrenia

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Neuroleptic malignant syndrome is a rare but serious adverse effect of antipsychotic medication. The author describes three new cases and reviews 50 others published in the past 5 years. Demographic and clinical features, diagnosis, treatment, outcome, and pathophysiology are critically reviewed, and a new set of diagnostic criteria, incorporating physical signs and routine laboratory tests, is proposed.

          Related collections

          Author and article information

          Comments

          Comment on this article